Granules India Limited has achieved a significant milestone in environmental sustainability by receiving the highest A rating in Climate Change from the Carbon Disclosure Project (CDP) for 2025. This achievement represents a two-level improvement from the B rating the pharmaceutical company received in 2024, positioning it among industry leaders in climate responsibility.

CDP Rating Performance

The company's 2025 CDP assessment results demonstrate performance across multiple environmental categories:

Notably, Granules India has also achieved a B rating in Water Security, marking its first disclosure in this category.

Understanding CDP Rating Framework

The Carbon Disclosure Project employs a four-tier rating system to evaluate corporate environmental performance:

• Leadership (A-/A): Represents industry leadership in environmental sustainability
• Management (B-/B): Signifies effective management of environmental impacts
• Awareness (C-/C): Reflects a level of environmental engagement
• Disclosure (D-/D): Indicates the initial stage of environmental engagement

Granules India's achievement of an A rating places the company in the Leadership category, demonstrating its approach to climate change management and environmental stewardship.

Sustainability Commitment

This recognition underscores Granules India's commitment to sustainability and climate responsibility. The company's expansion into Water Security and Forests categories for the first time, achieving B and B- ratings respectively, indicates an approach to environmental management across multiple domains.

About Carbon Disclosure Project

The Carbon Disclosure Project is a global non-profit organization that promotes transparency in environmental reporting. CDP helps companies and organizations disclose their impacts on climate change, water security, and deforestation. By providing insights through CDP ratings, the organization enables investors, companies, and stakeholders to make informed decisions and take action toward a more sustainable future.

The improved CDP rating positions Granules India as a leader in pharmaceutical industry sustainability practices and reflects the company's focus on environmental responsibility and climate action initiatives.

Granules India Limited has announced a strategic expansion of its North American operations through the incorporation of a new wholly-owned subsidiary in Canada. This move marks a significant step in the company's international growth strategy.

Key Details of the Expansion

Strategic Implications

This corporate action represents a calculated move by Granules India to strengthen its foothold in the North American pharmaceutical market. By establishing a presence in Canada through its existing U.S. subsidiary structure, the company is positioning itself to:

1. Expand its geographical reach in North America
2. Potentially tap into the Canadian pharmaceutical market
3. Create a platform for future growth and business opportunities in Canada

Regulatory Compliance

Granules India has informed the National Stock Exchange of India Limited and BSE Limited about this development, in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015.

Outlook

While the newly incorporated Granules Pharmaceuticals Canada, Inc. has not yet commenced business operations, this move signals Granules India's commitment to international expansion and its focus on the North American market. This strategic initiative could potentially open up new avenues for product development, market access, and regulatory expertise in the North American continent.